As I have previously discussed, I am participating in the Protégé Encore study, which is an anti-CD3 monoclonal antibody clinical trial that is…
On Monday, my daily life, my career path, and my work-related goals will change substantially. You see, Friday was my last day working at an exceptional…
A new study by University of Pittsburgh researchers has found that women who exclusively breastfeed their children for at least one month are less likely to develop type 2 diabetes.
The researchers studied the records of 2233 women, including 1828 mothers of which 56% breastfed their children for at least one month...
Tabbouleh is a popular Middle Eastern dish often served as an appetizer...
My dad had his first heart attack when he was 48, but didn't develop diabetes until about 10 years later.
The long and short of this is that I have to be careful...
Dr. William R. Kirtley, a medical researcher pioneer who helped develop drugs after World War II that greatly improved the lives of diabetics, has died at the age of 96.
Kirtley was part of a research team at Eli Lilly & Company in Indianapolis that conducted groundbreaking research on diabetes drugs after the war...
This is the first in a series of interviews with change leaders in diabetes. Dr. Steven V. Edelman, founder of Taking Control of Your Diabetes (TCOYD),…
Health Canada is informing Canadians that Novo Nordisk Canada Inc. has agreed to voluntarily recall two lots (YW60335 and YW60351) of their product, GlucaGen Hypokit (DIN 02333627) currently available on the Canadian market...
Novo Nordisk announced today the availability of NovoDoseTM – the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk’s modern insulin analog portfolio...
The continuing controversy surrounding the cardiovascular risk of GlaxoSmithKline's diabetes drug Avandia has led to sharp declines in its use and a surge in sales of the competing drug, Actos. Although the drugs are similar and both had FDA warnings in 2007, Takeda's Actos has been...